-
1دورية أكاديمية
المؤلفون: Garrido-Sánchez, Lucía, Gómez-Revuelta, Marcos, Ortiz-García de la Foz, Víctor, Pelayo-Terán, José María, Juncal-Ruiz, María, Ruiz-Veguilla, Miguel, Mayoral-Van Son, Jacqueline, Ayesa-Arriola, Rosa, Vázquez-Bourgon, Javier, Crespo-Facorro, Benedicto
مصطلحات موضوعية: Antipsychotics, drug-naïve, effectiveness, first-episode-psychosis, schizophrenia, Humans, Aripiprazole, Risperidone, Prospective Studies, Antipsychotic Agents, Psychotic Disorders, Treatment Outcome
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/10668/19804Test; PMC9670751; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670751/pdfTest
الإتاحة: https://doi.org/10.1093/ijnp/pyac047Test
http://hdl.handle.net/10668/19804Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670751/pdfTest -
2دورية أكاديمية
المؤلفون: Vázquez-Bourgon, Javier, Ortiz-García de la Foz, Víctor, Gómez-Revuelta, Marcos, Mayoral-van Son, Jacqueline, Juncal-Ruiz, María, Garrido-Torres, Nathalia, Crespo-Facorro, Benedicto
مصطلحات موضوعية: Metabolism, schizophrenia, second-generation antipsychotic, treatment-naïve, weight gain, Humans, Aripiprazole, Risperidone, Antipsychotic Agents, Psychoses, Substance-Induced, Metabolome, Lipids, Psychotic Disorders
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/10668/19803Test; PMC9593219; https://doi.org/10.1093/ijnp/pyac033Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593219/pdfTest
الإتاحة: https://doi.org/10.1093/ijnp/pyac033Test
http://hdl.handle.net/10668/19803Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593219/pdfTest -
3دورية أكاديمية
المؤلفون: Setién-Suero, Esther, Ortiz-Garcia de la Foz, Victor, Suárez-Pinilla, Paula, Crespo-Facorro, Benedicto, Ayesa Arriola, Rosa
المساهمون: Instituto de Salud Carlos III, Instituto de Investigación Marqués de Valdecilla
مصطلحات موضوعية: First episode of psychosis, Cognition, Risperidone, Aripiprazole, psy, socio
-
4دورية أكاديمية
المؤلفون: Crespo-Facorro, Benedicto, Ortiz-Garcia de la Foz, Victor, Mata, Ignacio, Ayesa-Arriola, Rosa, Suarez-Pinilla, Paula, Valdizan, Elsa M., Luis Vazquez-Barquero, Jose, Perez-Iglesias, Rocio
المصدر: Crespo-Facorro , B , Ortiz-Garcia de la Foz , V , Mata , I , Ayesa-Arriola , R , Suarez-Pinilla , P , Valdizan , E M , Luis Vazquez-Barquero , J & Perez-Iglesias , R 2013 , ' Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial ' , Schizophrenia Research , vol. 147 , no. 2-3 , pp. 375-382 . https://doi.org/10.1016/j.schres.2013.04.014Test
مصطلحات موضوعية: Antipsychotic agents, Schizophrenia, Adverse effects, Psychotherapeutic processes, ANTIPSYCHOTIC-DRUGS, RATING-SCALE, 2ND-GENERATION ANTIPSYCHOTICS, DEPRESSIVE SYMPTOMS, CLINICAL-TRIAL, OLANZAPINE, HALOPERIDOL, RISPERIDONE, EFFICACY, psy, socio
العلاقة: https://kclpure.kcl.ac.uk/portal/en/publications/aripiprazole-ziprasidone-and-quetiapine-in-the-treatment-of-firstepisode-nonaffective-psychosis-a-12week-randomized-flexibledose-openlabel-trialTest(d09a703c-b7b0-4584-913c-3cf207220f19).html
-
5دورية أكاديمية
المؤلفون: Juncal-Ruiz, María1 mjuncal11@gmail.com, Riesco-Dávila, Laura1, Ortiz-García de la Foz, Víctor1, Martínez-Garcia, Obdulia1, Ramírez-Bonilla, Mariluz1, Ocejo-Viñals, Javier Gonzalo1, Leza, Juan Carlos1, López-Hoyos, Marcos1, Crespo-Facorro, Benedicto1 bcfacorro@humv.es
المصدر: Schizophrenia Research. Dec2018, Vol. 202, p226-233. 8p.
مصطلحات موضوعية: *DRUG therapy for psychoses, *ARIPIPRAZOLE, *RISPERIDONE, *ANTIPSYCHOTIC agents, *ANTI-inflammatory agents, *CYTOKINES, *CHEMOKINES
-
6دورية أكاديمية
المؤلفون: Gómez-Revuelta, Marcos1 (AUTHOR) marcos.gomezr@scsalud.es, Pelayo-Terán, José María1,2,3 (AUTHOR), Vázquez-Bourgon, Javier1,2 (AUTHOR), Ortiz-García de la Foz, Víctor1,2 (AUTHOR), Mayoral-van Son, Jacqueline1,2,4 (AUTHOR), Ayesa-Arriola, Rosa1,2 (AUTHOR), Crespo-Facorro, Benedicto1,2,4 (AUTHOR)
المصدر: European Neuropsychopharmacology. Jun2021, Vol. 47, p74-85. 12p.
مصطلحات موضوعية: *ARIPIPRAZOLE, *RISPERIDONE, *TERMINATION of treatment, *ANTIPSYCHOTIC agents, *CLINICAL trials, *DRUG labeling, *PATIENT preferences, *LABELS